Sieper, Joachim

Prevention and treatment of low back pain: evidence, challenges, and promising directions

Foster, N. E., Anema, J. R., Cherkin, D., Chou, R., Cohen, S. P., Gross, D. P., Ferreira, P. H., Fritz, J. M., Koes, B. W., Peul, W., et al. (2018) · The Lancet

Musculoskeletal pain and rehabilitationSpine and Intervertebral Disc Pathology

Cited by 2,398

Low back pain: a call for action

Buchbinder, R., van Tulder, M., Öberg, B., Costa, L. M., Woolf, A., Schoene, M., Croft, P., Buchbinder, R., Hartvigsen, J., Cherkin, D., et al. (2018) · The Lancet

Musculoskeletal pain and rehabilitationSpine and Intervertebral Disc Pathology

Cited by 1,242

Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study

Baeten, D., Østergaard, M., Wei, J. C.-C., Sieper, J., Järvinen, P., Tam, L.-S., Salvarani, C., Kim, T.-H., Solinger, A., Datsenko, Y., et al. (2018) · Annals of the Rheumatic Diseases

Spondyloarthritis Studies and TreatmentsPsoriasis: Treatment and Pathogenesis

Cited by 390

Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial

McInnes, I. B., Sieper, J., Braun, J., Emery, P., van der Heijde, D., Isaacs, J. D., Dahmen, G., Wollenhaupt, J., Schulze-Koops, H., Kogan, J., et al. (2014) · Annals of the Rheumatic Diseases

Spondyloarthritis Studies and TreatmentsPsoriasis: Treatment and Pathogenesis

Cited by 343

Comparison of a high sensitivity and standard C reactive protein measurement in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis

Poddubnyy, D., Rudwaleit, M., Listing, J., Braun, J., & Sieper, J. (2010) · Annals of the Rheumatic Diseases

Spondyloarthritis Studies and TreatmentsOsteomyelitis and Bone Disorders Research

Cited by 85